[Guidelines for the treatment of invasive fungal infection. Invasive fungal infection by Candida spp. Invasive Fungal Infection Study Group (MICOMED) and Infection in Transplantation Study Group (GESITRA) of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC)].
These guidelines resume different issues related to the clinical management of invasive candidosis in the immunossuppressed patients. They are based on the recommendations of the different Drug's Agencies.
Gavaldà
Joan
J
Grupos de Estudio de la Infección Fúngica Invasora (MICOMED) y de Estudio de la Infección en el Trasplante (GESITRA) de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), Spain. iruiz@hg.vhebron.es
Ruiz
Isabel
I
D000935:Antifungal Agents / Q000008:administration & dosage / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy*; D019090:Case Management; D002908:Chronic Disease; D003453:Cryptococcosis / Q000188:drug therapy; D004347:Drug Interactions; D016469:Fungemia / Q000188:drug therapy; D015658:HIV Infections / Q000150:complications; D006801:Humans; D009928:Organ Specificity
D000935:Antifungal Agents